DE69822510D1 - Identifizierung und charakterisierung von interagierenden molekülen - Google Patents

Identifizierung und charakterisierung von interagierenden molekülen

Info

Publication number
DE69822510D1
DE69822510D1 DE69822510T DE69822510T DE69822510D1 DE 69822510 D1 DE69822510 D1 DE 69822510D1 DE 69822510 T DE69822510 T DE 69822510T DE 69822510 T DE69822510 T DE 69822510T DE 69822510 D1 DE69822510 D1 DE 69822510D1
Authority
DE
Germany
Prior art keywords
interacting molecules
identification
present
characterization
positive clones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69822510T
Other languages
English (en)
Other versions
DE69822510T2 (de
Inventor
Erich Wanker
David Bancroft
Hans Lehrach
Niels Wedemeyer
Elmar Maier
Sebastian Meier-Ewert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Application granted granted Critical
Publication of DE69822510D1 publication Critical patent/DE69822510D1/de
Publication of DE69822510T2 publication Critical patent/DE69822510T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1055Protein x Protein interaction, e.g. two hybrid selection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Vending Machines For Individual Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69822510T 1997-11-27 1998-11-27 Identifizierung und charakterisierung von interagierenden molekülen Expired - Fee Related DE69822510T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP97120879 1997-11-27
EP97120867 1997-11-27
EP97120879 1997-11-27
EP97120867 1997-11-27
EP97120880 1997-11-27
EP97120880 1997-11-27
PCT/EP1998/007656 WO1999028744A1 (en) 1997-11-27 1998-11-27 Identification and characterization of interacting molecules

Publications (2)

Publication Number Publication Date
DE69822510D1 true DE69822510D1 (de) 2004-04-22
DE69822510T2 DE69822510T2 (de) 2005-03-24

Family

ID=27238345

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69824757T Expired - Fee Related DE69824757T2 (de) 1997-11-27 1998-11-27 Identifizierung und charakterisierung von interagierenden molekülen mittels automatisierter interagierender paarung
DE69822510T Expired - Fee Related DE69822510T2 (de) 1997-11-27 1998-11-27 Identifizierung und charakterisierung von interagierenden molekülen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69824757T Expired - Fee Related DE69824757T2 (de) 1997-11-27 1998-11-27 Identifizierung und charakterisierung von interagierenden molekülen mittels automatisierter interagierender paarung

Country Status (10)

Country Link
US (1) US6664048B1 (de)
EP (3) EP1036324B1 (de)
JP (3) JP2002507386A (de)
AT (2) ATE269974T1 (de)
AU (3) AU760908B2 (de)
CA (3) CA2311705A1 (de)
DE (2) DE69824757T2 (de)
GB (1) GB2338711B (de)
IL (3) IL136392A0 (de)
WO (3) WO1999028745A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029847B2 (en) 2000-05-16 2006-04-18 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
WO2001088197A2 (en) 2000-05-16 2001-11-22 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
US20030219825A1 (en) * 2000-06-13 2003-11-27 Haizlip Jill Elaine High throughput method for screening candidate compounds for biological activity
WO2001098534A2 (en) * 2000-06-23 2001-12-27 Domantis Limited Matrix screening method
JP4024994B2 (ja) 2000-06-30 2007-12-19 株式会社東芝 半導体発光素子
AU2001278872A1 (en) 2000-07-06 2002-01-21 Genvec, Inc. Method of identifying a binding partner of a gene product
ATE396539T1 (de) 2000-07-13 2008-06-15 Ct Concept Technologie Ag Verfahren und vorrichtung zur zustandsabhängigen regelung des transienten verhaltens von leistungshalbleiterschaltern
CA2423552A1 (en) * 2000-10-13 2002-04-18 Irm Llc High throughput processing system and method of using
EP1364212B1 (de) 2001-03-02 2011-02-02 GPC Biotech AG Drei-hybrid-assaysystem
EP1243327A1 (de) * 2001-03-19 2002-09-25 BioChip Technologies GmbH Oberfläche mit einem Muster aus Zellen und Verfahren zu deren Herstellung
US7219016B2 (en) * 2001-04-20 2007-05-15 Yale University Systems and methods for automated analysis of cells and tissues
WO2002103608A2 (en) * 2001-06-14 2002-12-27 Ramot University Authority For Applied Research & Industrial Development Ltd. Method of expanding a biological network
DE10141522C1 (de) * 2001-08-24 2003-03-06 Siemens Ag Verfahren zur Herstellung einer Leuchtstoffschicht
US20020094519A1 (en) * 2002-03-07 2002-07-18 Agencourt Bioscience Corporation Detection of protein interactions
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
US20050074780A1 (en) * 2003-10-01 2005-04-07 Bryhan Marie D. Device for analyzing slides
WO2006040154A2 (en) * 2004-10-14 2006-04-20 Dublin City University Prokaryotic two hybrid system
US8034180B2 (en) 2005-10-11 2011-10-11 Applied Materials, Inc. Method of cooling a wafer support at a uniform temperature in a capacitively coupled plasma reactor
US8157951B2 (en) 2005-10-11 2012-04-17 Applied Materials, Inc. Capacitively coupled plasma reactor having very agile wafer temperature control
US7988872B2 (en) 2005-10-11 2011-08-02 Applied Materials, Inc. Method of operating a capacitively coupled plasma reactor with dual temperature control loops
US8092638B2 (en) 2005-10-11 2012-01-10 Applied Materials Inc. Capacitively coupled plasma reactor having a cooled/heated wafer support with uniform temperature distribution
US8221580B2 (en) 2005-10-20 2012-07-17 Applied Materials, Inc. Plasma reactor with wafer backside thermal loop, two-phase internal pedestal thermal loop and a control processor governing both loops
US7932030B2 (en) * 2007-04-05 2011-04-26 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College System for pulling out regulatory elements using yeast
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
BRPI0816785A2 (pt) 2007-09-14 2017-05-02 Adimab Inc bibliotecas de anticorpos sintéticos racionalmente desenhadas, e, usos para as mesmas
KR102024922B1 (ko) 2010-07-16 2019-09-25 아디맵 엘엘씨 항체 라이브러리
WO2018011422A1 (en) * 2016-07-15 2018-01-18 Danmarks Tekniske Universitet Plating cells and corresponding picking colonies
US20210285062A1 (en) * 2017-05-16 2021-09-16 The Regents Of The University Of California Fluorescence detection in yeast colonies
WO2021092323A1 (en) * 2019-11-06 2021-05-14 General Automation Lab Technologies Inc. Method for picking biological sample

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5789184A (en) 1993-03-31 1998-08-04 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US5503977A (en) 1994-04-22 1996-04-02 California Institute Of Technology Split ubiquitin protein sensor
AU716893B2 (en) * 1995-04-11 2000-03-09 General Hospital Corporation, The Reverse two-hybrid systems
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
EP0790304A1 (de) * 1995-12-21 1997-08-20 AMERSHAM INTERNATIONAL plc Auf Nachweismethoden bezogene Verbesserungen
US6083693A (en) * 1996-06-14 2000-07-04 Curagen Corporation Identification and comparison of protein-protein interactions that occur in populations
AU4159697A (en) * 1996-08-23 1998-03-06 President And Fellows Of Harvard College Interaction trap assay, reagents and uses thereof

Also Published As

Publication number Publication date
DE69824757T2 (de) 2005-10-20
CA2311705A1 (en) 1999-06-10
ATE269974T1 (de) 2004-07-15
CA2311927A1 (en) 1999-06-10
ATE262178T1 (de) 2004-04-15
DE69824757D1 (de) 2004-07-29
GB2338711B (en) 2000-11-15
JP2002507386A (ja) 2002-03-12
CA2311896A1 (en) 1999-06-24
GB9923293D0 (en) 1999-12-08
WO1999028745A1 (en) 1999-06-10
EP1042670A1 (de) 2000-10-11
IL136394A0 (en) 2001-06-14
AU760908B2 (en) 2003-05-22
EP1042670B1 (de) 2004-03-17
AU762954B2 (en) 2003-07-10
AU2050499A (en) 1999-06-16
AU2050599A (en) 1999-06-16
EP1036324A1 (de) 2000-09-20
GB2338711A8 (en) 2000-01-26
GB2338711A (en) 1999-12-29
AU1757599A (en) 1999-07-05
JP2001525186A (ja) 2001-12-11
US6664048B1 (en) 2003-12-16
WO1999028744A1 (en) 1999-06-10
JP2002508517A (ja) 2002-03-19
DE69822510T2 (de) 2005-03-24
EP1036324B1 (de) 2004-06-23
IL136393A0 (en) 2001-06-14
IL136392A0 (en) 2001-06-14
EP1036329A1 (de) 2000-09-20
WO1999031509A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
DE69822510D1 (de) Identifizierung und charakterisierung von interagierenden molekülen
DE69612017D1 (de) Emulsion zur robusten erfassung von gasen
DK0988534T3 (da) Elektroniske fremgangsmåder og apparat til detektering af analytter
DE69837703D1 (de) Methoden zum nachweis und zur analyse von virus
PT1456662E (pt) Deteccao de auto-anticorpos de pacientes que sofrem de artrite reumatoide
ATE205884T1 (de) Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie
DK0529065T3 (da) Receptorbaserede fremgangsmåder til screening for amylinagonister og -antagonister
DE69719057D1 (de) Verfahren zur signalverstärkung
ATE336591T1 (de) Nachweisverfahren für kurze sequenzvarianten
BR9812783A (pt) "sistemas de detecção para o registro de interações e as relações funcionais de proteìnas"
DK0698093T3 (da) Von Hippel-Lindau-(VHL)-sygdomsgen og tilsvarende cDNA og metoder til påvisning af bærere af VHL-sygdomsgenet
DE58903466D1 (de) Sonde zur entnahme von aggressiven gasen aus kanaelen, insbesondere rauchgaskanaelen.
ATE317451T1 (de) Verfahren zur diagnose, erkennung, und einstufung von dickdarmkrebs
DE69902924D1 (de) Neue methoden zum auffinden von liganden- und ziel-biomolekülen
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
DE69731964D1 (de) Map-kinase: polypeptide, polynukleotide und ihre verwendung
ES2168310T3 (es) Reactivos y metodos de deteccion y de cuantificacion de la testosterona en muestras de fluido.
ATE449868T1 (de) Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen
WO2002058533A3 (en) Process for determining target function and identifying drug leads
DE68919387D1 (de) DNS- und RNS-Proben, Methoden und Testsätze zum Nachweis von Salmonella.
ATE412067T1 (de) Polypeptide mit spezieller, funktioneller domäne, verfahren zu ihrer identifikation und anwendungen derselben
DE60028374D1 (de) Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays
DE60025380D1 (de) Ein-schritttest zum nachweis von antimikrobiellen rückständen in eiern
DE69433962D1 (de) Biosensor zum Nachweis von Metallionen
EP1268842A4 (de) Verbessertes verfahren für reverses n-hybrid-screening

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee